Bluejay Diagnostics (BJDX) Inventory Average (2022 - 2025)

Bluejay Diagnostics (BJDX) reported Inventory Average of $600.0 for Q3 2025, down 99.44% sequentially from $107827.0 in Q4 2024.

Bluejay Diagnostics (BJDX) Inventory Average (2022 - 2025) Analysis & Trends

Bluejay Diagnostics (BJDX) has 3 years of Inventory Average data on file, last reported at $600.0 in Q3 2025.

  • For the quarter ending Q3 2025, Inventory Average changed N/A year-over-year to $600.0; the trailing twelve-month figure through Sep 2025 stood at $600.0 (changed N/A YoY), and the FY2024 full-year result was $290452.5, down 53.16% from the prior year.
  • Inventory Average retreated to $600.0 in Q3 2025, from $107827.0 in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $782212.0 in Q2 2022 to a low of $600.0 in Q3 2025.
  • A 3-year average of $354306.5 and a median of $317207.0 in 2022 frame the typical range for Inventory Average.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inventory Avg. (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 6.74 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 5.36 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 6.13 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 3.03 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 1.12 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 661.35 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 3.49 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 2.29 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - 2.29 Bn
10 Bluejay Diagnostics 2,754.24 2,754.24 - -

Historic Data

Download Data
DateValue
Sep 30, 2025 600.00
Dec 31, 2024 107,827.00
Jun 30, 2022 782,212.00
Mar 31, 2022 526,587.00